Hossein Ardeschir Ghofrani MD

Morphogen-IX Scientific Advisory Board

Hossein A. Ghofrani is Professor for Pulmonary Vascular Research at Justus Liebig University Giessen, Germany. He is Head of the Pulmonary Hypertension Division at the University Hospital in Giessen, and Director of Pneumology as well as Medical Executive Director at the Kerckhoff Clinic in Bad Nauheim, Germany. He is also part-time Professor for Pulmonary Vascular Medicine at Imperial College London. He leads a translational research group on development of new therapeutics for Cardiopulmonary Vascular disease. He is member of the steering committee of the Excellence Cluster Cardio-Pulmonary System (www.eccps.de) and founding member of the Pulmonary Vascular Research Institute (www.pvri.info). He has participated in the development of several therapeutics for chronic lung diseases and pulmonary hypertension, including prostanoids, phosphodiesterase inhibitors, endothelin receptor antagonists, tyrosine kinase inhibitors, and stimulators of the soluble guanylate cyclase. He has received four awards for investigations in pulmonary vascular science, is a Fellow of the European Respiratory Society (FERS) and reviewer for several medical scientific journals.

Developing BMPs as novel treatments for pulmonary arterial hypertension